Lotus Pharm vs BioLASCO Taiwan: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and BioLASCO Taiwan (6662) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ BioLASCO Taiwan

0%+226%-47%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYBioLASCO TaiwanYoY
Oct 2026NT$2.13 billion-22.5%NT$19.5 million+6.7%
Sep 2026NT$2.77 billion+128.0%NT$21.3 million+1.5%
Aug 2026NT$2.11 billion+81.7%NT$26.7 million+32.8%
Jul 2026NT$2.49 billion+3.9%NT$23.8 million+7.3%
Jun 2026NT$3.4 billion+225.5%NT$22.9 million+5.3%
May 2026NT$2.32 billion+105.8%NT$19.3 million-19.4%
Apr 2026NT$3.09 billion+19.9%NT$22.3 million-9.3%
Mar 2026NT$4.35 billion+173.6%NT$26.2 million+28.1%
Feb 2026NT$2.24 billion+131.5%NT$10.4 million-47.1%
Jan 2026NT$2.05 billion-5.5%NT$24.5 million+23.4%
Dec 2025NT$2.44 billion+66.9%NT$29.4 million-15.4%
Nov 2025NT$1.06 billion-0.2%NT$21.6 million-6.7%
Oct 2025NT$2.75 billion+46.0%NT$18.3 million-29.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16